Overview


According to FutureWise analysis the market for Peripheral Vascular Devices in 2023 is US$ 11.47 billion, and is expected to reach US$ 17.63 billion by 2031 at a CAGR of 5.50%.

Peripheral arterial disease (PAD) is caused by blocking or narrowing of the blood vessels owing to the build-up of plaque. This condition can result in aneurysms, kidney diseases, the death of tissue, heart stroke in cases when left untreated. As per the National Institute of Health, one in concerning people over 50 years, one in every 20 American has PAD. It has influenced over eight to 12 million people in the U.S, particularly to those over the age of 50.
As the population is constantly increasing, the incidences of disease are rising which could proliferate from over 10 million to reach an overall of 20 million worldwide by 2050. With the ageing of the population around the world, it possibly seems that PAD will be normalised in the upcoming years. Therefore, as per the statistics have revealed, the number of peripheral arterial disease is rising at a quicker pace, which is gradually driving the peripheral vascular devices market. Other factors like the growing demand for minimally-invasive surgeries for peripheral arterial disease, in particular, lifestyle changes, technological advancements and increase in the geriatric population have expanded the market size.

Based on type, the peripheral vascular devices market is bifurcated into embolic projection devices, peripheral guidewires, peripheral stents grafts, peripheral venous thrombectomy device, vena cava filters, angioplasty catheters and PTA balloons. Peripheral vascular stents graft accounts for the largest market share. Angioplasty catheter segment is predicted to showcase substantial growth over the forecast period.
Geographically, the market is fragmented into North America, Europe, Asia Pacific and the rest of the world. North America dominates the peripheral vascular devices market which is followed by the Europe region. The Asia Pacific region is anticipated to proliferate during the forecast period owing to the increasing prevalence of peripheral vascular diseases. Manufacturers of peripheral vascular devices are slowly adopting integral developmental strategies to create innovative devices. Many clinical trials are currently in progress to increase device efficacy and safety.

  • Medtronic
  • Becton, Dickinson and Company
  • Terumo Corporation
  • Boston Scientific Corporation
  • Abbott
  • Cardinal Health
  • iVascular
  • B. Braun Melsungen
  • Biosensors International Group
  • Biotronik SECo. KG
  • Penumbra Inc.

By Product

  • Angioplasty Balloons
    • Old/Normal Balloons
    • Drug-eluting Balloons
    • Cutting and Scoring Balloons
  • Angioplasty Stents
    • Drug-eluting Stents
    • Bare-metal Stents
      • Self-expandable Stents
      • Balloon-expandable Stents
  • Catheters
    • Angiography Catheters
    • Guiding Catheters
    • IVUS/OCT Catheters
  • EVAR Stent Grafts
    • Abdominal Aortic Aneurysm Stent Grafts
    • Thoracic Aortic Aneurysm Stent Grafts
  • Inferior Vena Cava Filters
    • Retrievable Filters
    • Permanent Filters
  • Plaque Modification Devices
    • Atherectomy Devices
    • Thrombectomy Devices
  • Hemodynamic Flow Alteration Devices
    • Embolic Protection Devices
    • Chronic Total Occlusion Devices
  • Other Devices
    • Guidewires
    • Vascular Closure Devices
    • Introducer Sheaths
    • Balloon Inflation Devices

By Region

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East and Africa

  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants

  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth

  • To provide with an exhaustive analysis on the Invisible Braces Market By Product and By Region.
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Peripheral Vascular Devices Market Variables, Trends and Scope
    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Peripheral Vascular Devices Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Peripheral Vascular Devices Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Peripheral Vascular Devices Market, By Product Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Angioplasty Balloons
         1.1. Old/Normal Balloons
         1.2. Drug-eluting Balloons
         1.3. Cutting and Scoring Balloons
        2. Angioplasty Stents
         2.1. Drug-eluting Stents
         2.2. Bare-metal Stents
          2.2.1. Self-expandable Stents
          2.2.2. Balloon-expandable Stents
        3. Catheters
         3.1. Angiography Catheters
         3.2. Guiding Catheters
         3.3. IVUS/OCT Catheters
        4. EVAR Stent Grafts
         4.1. Abdominal Aortic Aneurysm Stent Grafts
         4.2. Thoracic Aortic Aneurysm Stent Grafts
        5. Inferior Vena Cava Filters
         5.1. Retrievable Filters
         5.2. Permanent Filters
        6. Plaque Modification Devices
         6.1. Atherectomy Devices
         6.2. Thrombectomy Devices
        7. Hemodynamic Flow Alteration Devices
         1. Embolic Protection Devices
         2. Chronic Total Occlusion Devices
        8. Other Devices
         8.1. Guidewires
         8.2. Vascular Closure Devices
         8.3. Introducer Sheaths
         8.4. Balloon Inflation Devices

  • 8.   North America Peripheral Vascular Devices Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 9.   Latin America Peripheral Vascular Devices Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 10.   Europe Peripheral Vascular Devices Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.7. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 11.   Asia Pacific Peripheral Vascular Devices Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 12.   Middle East and Africa Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 13.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 14.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    •   1. Medtronic
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. Becton, Dickinson and Company
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. Terumo Corporation
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. Boston Scientific Corporation
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. Abbott
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. Cardinal Health
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. iVascular
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. B. Braun Melsungen
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
        9. Biosensors International Group
         9.1. Company Overview
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview
        10.Biotronik SECo. KG
         10.1. Company Overview
         10.2. Product Portfolio
         10.3. SWOT Analysis
         10.4. Financial Overview
         10.5. Strategic Overview
        11.Penumbra Inc.
         11.1. Company Overview
         11.2. Product Portfolio
         11.3. SWOT Analysis
         11.4. Financial Overview
         11.5. Strategic Overview

  • 15.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the healthcare regulations initiated by administrations
        5. The overall economic slowdown of the developing and developed nations
  • 16.   FutureWise SME Key Takeaway Points for Client
Partner

Our Clients